Literature DB >> 191400

Oncogenicity of avian leukosis viruses of different subgroups and of mutants of sarcoma viruses.

H G Purchase, W Okazaki, P K Vogt, H Hanafusa, B R Burmester, L B Crittenden.   

Abstract

Leukosis viruses of seven subgroups were tested for oncogenicity in chickens susceptible to virus infection and to development of lymphoid leukosis (LL) tumors. All subgroup A viruses and the subgroup B virus tested produced a high incidence of LL and other related neoplasms. Viruses of subgroup C and RAV-61 of subgroup F produced a low level of LL. The RAV-50 of subgroup D produced osteopetrosis. In these tests, the viruses of subgroup E and G and one virus of subgroup F were not pathogenic, possibly because infection was not established in the chickens, the chickens were not susceptible to tumor development by these viruses, or the viruses lacked oncogenicity. All temperature-sensitive mutants of Rous sarcoma virus produced sarcomas, but the level varied. One nontransforming mutant produced sarcomas, and the other three tested produced LL. All three mutants that cause cells to grow as colonies in agar produced a high incidence of sarcomas. Thus, sarcoma viruses, by back-mutation, may lose the ability to transform cells in vitro, to make cells grow in agar colonies, or to induce sarcomas in vivo, yet they retain the ability to produce LL. Conversely, it was previously shown that leukosis viruses may be changed into viruses that transform cells in vitro and produce sarcomas in vivo by suitable passage in chicks.

Entities:  

Mesh:

Year:  1977        PMID: 191400      PMCID: PMC421385          DOI: 10.1128/iai.15.2.423-428.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS. 3. DETERMINING INFLUENCE OF A NEW HELPER VIRUS ON THE HOST RANGE AND SUSCEPTIBILITY TO INTERFERENCE OF RSV.

Authors:  H HANAFUSA
Journal:  Virology       Date:  1965-02       Impact factor: 3.616

2.  TRANSMISSION OF VIRUS FROM FIELD CASES OF AVIAN LYMPHOMATOSIS. I. ISOLATION OF VIRUS IN LINE 151 CHICKENS.

Authors:  B R BURMESTER; T N FREDRICKSON
Journal:  J Natl Cancer Inst       Date:  1964-01       Impact factor: 13.506

3.  Recombination between endogenous and exogenous RNA tumor virus genes as analyzed by nucleic acid hybridization.

Authors:  W S Hayward; H Hanafusa
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

4.  An avian leukosis virus associated with stocks of Rous sarcoma virus.

Authors:  H RUBIN; P K VOGT
Journal:  Virology       Date:  1962-05       Impact factor: 3.616

5.  Low oncogenic potential of avian endogenous RNA tumor virus infection or expression.

Authors:  J V Motta; L B Crittenden; H G Purchase; H A Stone; R L Witter
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

6.  Phenotypic mixing test to detect and assay avian leukosis viruses.

Authors:  W Okazaki; H G Purchase; B R Burmester
Journal:  Avian Dis       Date:  1975 Apr-Jun       Impact factor: 1.577

7.  Host gene control of endogenous avian leukosis virus production.

Authors:  L B Crittenden; E J Smith; R A Weiss; P S Sarma
Journal:  Virology       Date:  1974-01       Impact factor: 3.616

8.  Studies on the serological and interfering properties of avian leucosis virus isolates from field outbreaks of disease and from three vaccines.

Authors:  A E Churchill
Journal:  Res Vet Sci       Date:  1968-01       Impact factor: 2.534

9.  Strain MC29 avian leukosis virus. Myelocytoma, endothelioma, and renal growths: pathomorphological and ultrastructural aspects.

Authors:  Z Mladenov; U Heine; D Beard; J W Beard
Journal:  J Natl Cancer Inst       Date:  1967-03       Impact factor: 13.506

10.  Determining factor in the capacity of Rous sarcoma virus to induce tumors in mammals.

Authors:  H Hanafusa; T Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1966-03       Impact factor: 11.205

View more
  19 in total

Review 1.  Lymphoid leukosis viruses, their recognition as 'persistent' viruses and comparisons with certain other retroviruses of veterinary importance.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses.

Authors:  M M Goodenow; W S Hayward
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Endogenous oncornaviral antigen in the bursa of Fabricius of 15B X 7(2) chickens.

Authors:  J M England; M S Halpern
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

4.  Specificity of avian leukosis virus-induced hyperlipidemia.

Authors:  J K Carter; R E Smith
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Induction of angiosarcomas by ring-necked pheasant virus.

Authors:  J K Carter; S J Proctor; R E Smith
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity.

Authors:  J K Carter; C L Ow; R E Smith
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Induction of neoplasms by subgroup E recombinants of exogenous and endogenous avian retroviruses (Rous-associated virus type 60).

Authors:  L B Crittenden; W S Hayward; H Hanafusa; A M Fadly
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

8.  Size and genetic content of viral RNAs in avian oncovirus-infected cells.

Authors:  W S Hayward
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  Isolation of 16L virus: a rapidly transforming sarcoma virus from an avian leukosis virus-induced sarcoma.

Authors:  B G Neel; L H Wang; B Mathey-Prevot; T Hanafusa; H Hanafusa; W S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  Temperature-sensitive tumorigenicity of cells transformed by a mutant of Moloney sarcoma virus.

Authors:  J K Klarlund; J Forchhammer
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.